Arvinas, Pfizer's Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment
Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in collaboration with Pfizer Inc.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 48,390,268 | $1,172,980,101 | +3% | 0.47% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 18,718,955 | $453,747,469 | +44% | 0.32% |
| 3. | Diamond Hill Capital Ric Dillon | 17,664,353 | $428,183,917 | -6% | 1.97% |
| 4. | 15,977,200 | $387,287,328 | -19% | 0.07% | |
| 5. | Citadel Investment Group Ken Griffin | 14,866,203 | $360,356,761 | +112% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing | |
| $38.58 | 1,000 | $38,580.00 | 6,000 | 2023-05-08 | Filing | |
| $38.43 | 1,000 | $38,425.00 | 5,000 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing | |
| $50.50 | 4,000 | $202,000.00 | 15,064 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 533,363,457 | $12,928,730,197 | 0.21% | |
| 2. | 494,877,296 | $11,995,825,662 | 0.23% | |
| 3. | 296,301,310 | $7,182,343,754 | 0.27% | |
| 4. | 127,471,481 | $3,080,552,327 | 0.22% | |
| 5. | 93,653,338 | $2,270,156,913 | 0.28% |
News See All
Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral’ Rating
Following the company’s strong Q2 performance, Citi raised its price target on Pfizer Inc. (NYSE:PFE) from $25 to $26 on August 6, 2025, maintaining a ‘Neutral’ rating.
10 Most Undervalued Value Stocks to Buy Now
Expectations of easing inflation resulted in renewed hopes that the Federal Reserve could potentially cut interest rates as soon as next month. As a result, U.S.
10 Stocks Jim Cramer Discussed As He Questioned Official Data
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent controversy surrounding the Labor Department, where fresh jobs data made President Trump fire the head of the Bureau...
Should You Now Consider Selling Your Pfizer (PFE) Shares Before its Too Late?
Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S.
Pfizer Reports Positive Topline Phase 3 Results For HYMPAVZI™ In Hemophilia A or B With Inhibitors
Pfizer Inc. (NYSE:PFE) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Pfizer Inc.
11 Best GLP-1 and Weight Loss Stocks to Invest in
GLP-1 medicines are a type of prescription that mimics a natural hormone that regulates blood sugar and appetite.
Pfizer (PFE) Releases Financial Results for Q2 2025
Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds.
11 Most Undervalued Long Term Stocks to Buy According to Hedge Funds
BlackRock sees risk assets in a tug-of-war between strong US corporate earnings, driven by the AI theme, and tariffs that impact growth while increasing inflation.
Billionaire Hedge Funds
